CASHMAN JOHN R has a total of 11 patent applications. Its first patent ever was published in 2000. It filed its patents most often in United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are BEARSDEN BIO INC, CELLZOME AG and HOWARD FLOREY INST.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 10 | |
#2 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Measurement | |
#5 | Machines |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds | |
#4 | Analysing materials | |
#5 | Fermentation | |
#6 | Sugars | |
#7 | Acyclic or carbocyclic compounds | |
#8 | Peptides | |
#9 | Measuring microorganism processes | |
#10 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Cashman John R | 11 |
#2 | Macdonald Mary T | 2 |
#3 | Fiala Milan | 1 |
#4 | Lomri Noureddine | 1 |
#5 | Kalisiak Jarosiaw | 1 |
#6 | Abel Kenneth J | 1 |
#7 | Macdougall James M | 1 |
Publication | Filing date | Title |
---|---|---|
US2014051712A1 | Blood brain barrier-penetrating oximes for cholistenerases reactivation | |
US2012040976A1 | Small molecule immunomodulators for alzheimer's disease | |
WO2010039163A2 | Chemical and biochemical adducts as biomarkers for organophosphate exposure | |
US2008188527A1 | Synthetic Compounds and Derivatives as Modulators of Smoking or Nicotine Ingestion and Lung Cancer | |
US6762052B1 | DNA sequence encoding flavin-containing monooxygenase |